Wells Fargo Maintains Equal-Weight on aTyr Pharma, Raises Price Target to $4

Benzinga · 1d ago
Wells Fargo analyst Derek Archila maintains aTyr Pharma (NASDAQ:ATYR) with a Equal-Weight and raises the price target from $1 to $4.